Ajanta Pharma Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Ajanta Pharma Limited generated cash of $7,850,700,000, which is less than the previous year. Cash used in financing activities reached the amount of -$10,510,600,000 last year. Net change in cash is therefore -$2,014,400,000.
Cash Flow
| 2010 | 951.16M | -426.66M | -456.79M |
|---|---|---|---|
| 2011 | 1.00B | -405.43M | -601.16M |
| 2012 | 765.41M | -445.22M | -274.53M |
| 2016 | 3.26B | -2.09B | -1.18B |
| 2018 | 2.85B | -2.60B | -2M |
| 2020 | 4.56B | -2.24B | -1.28B |
| 2021 | 5.76B | -2.82B | -3.18B |
| 2023 | 7.91B | -5.59B | -1.07B |
| 2024 | 7.85B | 653.9M | -10.51B |
AJANTPHARM.NS Cash Flow Statement (2010 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 3.29B | 2.06B | 2.02B | 951.6M | 658.3M | 544.9M | 36.08M | 148.38M | 80.68M |
Operating activities | |||||||||
Net income | 8.16B | 7.45B | 9.00B | 6.63B | 6.22B | 5.47B | 772.65M | 507.12M | 340.03M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 1.35B | 1.30B | 1.16B | 957.2M | 595.9M | 450.6M | 318.69M | 247.48M | 207.33M |
Stock-based compensation expense | 54.9M | 2.2M | 200K | 4.2M | 13.4M | 3.1M | 0 | 0 | 0 |
| Deferred income tax benefit | 54.9M | 2.2M | 200K | 4.2M | 13.4M | 3.1M | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | -1.95B | -105.5M | 311.3M | -2.68B | -1.69B | -1.14B | 0 | 0 | 0 |
Inventories | -123M | -223.7M | -2.71B | -589.3M | -1.38B | -455.5M | -546.80M | 65.04M | -157.32M |
Accounts payable | 408.5M | 969.1M | 111.5M | 1.32B | 722.4M | 365.1M | 0 | 0 | 0 |
Cash generated by operating activities | 7.85B | 7.91B | 5.76B | 4.56B | 2.85B | 3.26B | 765.41M | 1.00B | 951.16M |
Investing activities | |||||||||
Purchases Of Investments | -20.79B | -16.66B | -7.42B | -2.78B | -2.32B | -469.3M | -25K | 0 | 0 |
Investments In Property Plant And Equipment | -1.52B | -1.74B | -1.71B | -2.39B | -2.62B | -2.96B | -493.19M | -406.58M | -428.65M |
Acquisitions Net | 0 | 183.7M | 17.1M | 54.9M | 1.1M | 4.3M | 0 | 0 | 0 |
Cash generated by investing activities | 653.9M | -5.59B | -2.82B | -2.24B | -2.60B | -2.09B | -445.22M | -405.43M | -426.66M |
Financing activities | |||||||||
Common Stock Issued | 0 | 0 | 440.2M | 0 | 0 | 100K | 0 | 0 | 0 |
Payments for dividends | -6.42B | -896.9M | -829M | -1.15B | -3M | -1.22B | -58.24M | -40.74M | -29.07M |
Repurchases of common stock | -3.89B | -14.4M | -1.35B | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 600K | -4.9M | -440.2M | -55.4M | 5.1M | 205.7M | 0 | 0 | 0 |
Cash used in financing activities | -10.51B | -1.07B | -3.18B | -1.28B | -2M | -1.18B | -274.53M | -601.16M | -456.79M |
Net Change In Cash | -2.01B | 1.24B | -243.6M | 1.03B | 248.1M | -14.8M | 45.65M | -781K | 67.70M |
Cash at end of period | 1.29B | 3.30B | 1.77B | 1.98B | 906.4M | 530.1M | 81.74M | 147.60M | 148.38M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |